Arcutis Biotherapeutics

Arcutis

This company develops and commercialises topical treatments for patients living with chronic immune-mediated dermatological diseases including psoriasis, seborrhoeic dermatitis and atopic dermatitis.

Dermira

This biopharmaceutical company develops and commercialises medical dermatology treatments for patients with chronic skin conditions such as excessive sweating and atopic dermatitis.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.

Krystal Biotech

This biotechnology company develops and commercialises redosable gene therapies for patients with rare genetic diseases, including dystrophic epidermolysis bullosa.

Evelo Biosciences

This biotechnology company develops orally delivered microbial medicines targeting the small intestinal axis to treat patients with inflammatory diseases like psoriasis and atopic dermatitis.

DermBiont

This clinical-stage biotechnology company develops targeted topical therapeutics to treat skin diseases, such as hyperpigmentation and seborrheic keratoses, for patients with dermatological conditions.

Brickell Biotech

This pharmaceutical company develops prescription therapeutics for patients with skin diseases, such as hyperhidrosis, atopic dermatitis, and acne.

Apogee Therapeutics

This biotechnology company develops monoclonal antibody therapies for patients with inflammatory and immunological diseases, including atopic dermatitis, asthma and chronic obstructive pulmonary disease.